| Product Name | : | Pandovir |
| Generic Name | : | Remdisivir |
| Formulation | : | Injection |
| Available Pack Size | : | 1’s |
| Available Strength | : | 100 mg |
-
Product Description: Beacon Pharmaceuticals Limited (BPL) has launched Pandovir 100, a broad-spectrum antiviral medicine, for the treatment of severe Covid-19 cases under the generic of Remdesivir. Directorate General of Drug Administration (DGDA) considered it as an Emergency Use Authorization (EUA) for the patients who are hospitalized with probable or laboratory-confirmed case of SARS-CoV-2. The medicine will be available in the market in a single strength --100mg –injection with a new packaging availing the brand name Pandovir,that will open a new horizon for treating the severely ill Covid-19 patients. The Packaging includes 2 vial (1 vial of Remdisivir 100 mg Lyophilized powder & 1 vial of 20 mL WFI) and a leaflet. Product Features: -
Product Description: Favipira is the preparation of favipiravir. Favipira is a drug the use of which is considered only when there is an outbreak of novel or re-emerging influenza virus infections in which other anti-influenza virus agents are not effective or insufficiently effective, and the government decides to use the drug as a countermeasure against such influenza’s viruses. When administering the drug, obtain the latest information including government’s direction of countermeasures a gain such influenza viruses, and prescribe only to appropriate patients. In present situation Favipira is using to treat COVID-19 patients. This drug is showing hope for the COVID-19 patients. Product Features:Product Name : Favipira Generic Name : Favipiravir Formulation : Tablet Available Pack Size : 200 mg (Oral Tablet) Available Strength : 2 x 10’s Registrations : Bangladesh -
Product Description: First new frontline treatment option for HCC approved in Japan Lenvatinib is amultikinase inhibitor that interrupts the pathways of VEGFR1,VEGFR2 and VEGFR3.It is used in the treatment of differentiated thyroid cancer (DTC),renal Cell Carcinoma and Hepatocellular Carcinoma (HCC) Product Features:Product Name : Lenvanix Generic Name : Lenvatinib Formulation : Capsule Available Pack Size : 30's Pot Available Strength : 4 mg and 10 mg Registrations Available Website : Lenvanix.com -
Product Description: Tofacitinib is indicated for the treatment of adult patients withmoderately to severely active rheumatoid arthritis who have hadan inadequate response or intolerance to methotrexate. It may beused as monotherapy or in combination with methotrexate orother nonbiologic disease-modifying antirheumatic drugs(DMARDs). Product Features:Product Name : Tofacinix Generic Name : Tofacitinib Formulation : Tablet Available Pack Size : 3x10's Alu-Alu Available Strength : 11 mg Registrations : Export Only Website : Tofacinix.com -
Product Description: Axinix (Axitinib) is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy. Product Features:Product Name : Axinix Generic Name : Axitinib Formulation : Tablet Available Pack Size : 180's Pot & 60's Po Available Strength : 1 mg & 5 mg Registrations : Export Only Website : Axinix.com -
Product Description: Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase domains of both EGFR (ErbB1) and of HER2 (ErbB2) receptors. Lapatinib retained significant activity against HER2-amplified breast cancer cell lines selected for long-term growth in trastuzumab-containing medium in vitro and was synergistic in combination with trastuzumab in these cell lines. Product Features:Product Name : Lapanix Generic Name : Lapatinib Formulation : Tablet Available Pack Size : 150's Pot Available Strength : 250 mg Registrations : Export Only Website : Lapanix.com -
Product Description: Baricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs. Baricitinib may be used as monotherapy or in combination with Methotrexate. Product Features:Product Name : Baricinix Generic Name : Baricitinib Formulation : Tablet Available Pack Size : 30's Pot Available Strength : 2mg & 4mg Registrations : Export Only Website : Baricinix.com -
Product Description: Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:- an aromatase inhibitor as initial endocrine based therapy in postmenopausal women.
- fulvestrant in women with disease progression following endocrine therapy.
Product Name : Palbonix Generic Name : Palbociclib Formulation : Capsule Available Pack Size : 21's Pot Available Strength : 125mg Registrations : Export Only Website : Palbonix.com -
Product Description: Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and Metastatic Thyroid Cancer. Product Features:Product Name : Cabozanix Generic Name : Cabozanitib Formulation : Tablet Available Pack Size : 90's Pot & 30's Pot Available Strength : 20mg & 60mg Registrations : Export Only Website : Cabozanix.com -
Product Description: Obetix is the only choice for Primary Biliary Cirrhosis (PBC) with the combination of UDCA (Ursodeoxycholic Acid) Product Features:Product Name : Obetix 5 Generic Name : Obeticholic Acid Formulation : Tablet Available Pack Size : 30's Pot Available Strength : 5 mg Registrations : Export Only Website : Obetix.com -
Product Description: Soforal LP is a fixed –dose combination tablet containing Ledipasvir and Sofosbuvir for oral administration.
Product Features:
Soforal LP is a fixed-dose combination of Ledipasvir, a hepatitis C virus (HCV) NS5A inhibitor, and Sofosbuvir, an HCV nucleotide analog NS5B polymerase inhibitor, and is indicated for the treatment of chronic hepatitis C virus (HCV) in: A. Adults with genotype 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis B. Adults with genotype 1 infection with decompensate cirrhosis, in combination with Ribavirin C. Adults with genotype 1 or 4 infection who are liver transplant recipients without cirrhosis or with compensated cirrhosis, in combination with Ribavirin.Product Name : Soforal LP Generic Name : Sofosbuvir + Ledipasvir Formulation : Tablet Available Pack Size : 6’s Available Strength : 400 mg + 90 mg Registrations : Bangladesh -
Sofosvel is the global first generic oral tablet for pan-genotypic Chronic Hepatitis C treatment. This combination (Sofosbuvir 400 mg + Valpatasvir 100 mg) drug has been approved by US FDA & European Commission for treatment of patients with all genotypic Chronic Hepatitis C virus infection. Sofosvel is used without cirrhosis or with compensated cirrhosis, and patients with advanced cirrhosis (Decompensated).
Therapeutic indications:
Sofosvel is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infections
- With or without cirrhosis or with compensated cirrhosis
- With decompensated cirrhosis for use in combination with Ribavirin
Product Name : Sofosvel
Generic Name : Sofosbuvir 400mg + Velpatasvir 100 mg
Formulation : Solid dosage form(Tablet)
Available pack size : 1×6’s
Strengths : 400mg+ 100mg